https://ift.tt/2IVHF6y

The US Food and Drug Administration (USFDA) has issued a warning letter to Torrent Pharma's Indrad (Gujarat) API and formulations facility.

from Markets https://ift.tt/2pZzZaJ

Comments

Popular posts from this blog

MPL accuses ASCI of 'tampering' with ads